StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

KRYS — Krystal Biotech, Inc.

EXPENSIVE (MOS -74.8%) · Quality 86/100

Price
336.67
Intrinsic value
192.62
Margin of safety
-74.8%
Implied growth (reverse DCF)
+23.4%
model assumes +16.0%
Value Score
24.7
Quality
86
Psychology
11
Discovery
28
price/volume attention only
Moat score
74.5
erosion: none

Value Score: bottom 38% of Russell 3000 · Quality: top 2%

Open the interactive Deep Dive for KRYS →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/KRYS - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is KRYS undervalued?

As of 2026-09-19, KRYS trades at 336.67 against a computed intrinsic value of 192.62 (-74.8% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Krystal Biotech, Inc.'s Value Score?

Krystal Biotech, Inc.'s Value Score is 24.7 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.